China
· Delayed Price · Currency is CNY Bloomage BioTechnology Corporation Company Description
Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials.
It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA.
The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names.
Bloomage BioTechnology Corporation Limited was founded in 2000 and is headquartered in Jinan, the People’s Republic of China.
| Country | Cayman Islands |
| Founded | 2000 |
| Industry | Specialty Chemicals |
| Sector | Materials |
| Employees | 4,655 |
| CEO | Yan Zhao |
Contact Details
Address: Tech Development Zone Jinan, 250101 China | |
| Phone | 86 531 8268 5998 |
| Website | bloomagebioactive.com |
Stock Details
| Ticker Symbol | 688363 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003NL9 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Yan Zhao | Chief Executive Officer |
| Hui Wang | Chief Financial Officer |